ALK(SZ:002940) Xin Lang Cai Jing·2025-11-12 03:29Group 1 - The core viewpoint of the news is that Anglikang's stock price increased by 5.09%, reaching 44.81 CNY per share, with a trading volume of 1.038 billion CNY and a turnover rate of 12.93%, resulting in a total market capitalization of 9.039 billion CNY [1] - Anglikang Pharmaceutical Co., Ltd. is located in Shengzhou, Zhejiang Province, and was established on December 30, 2001. It was listed on October 23, 2018. The company's main business involves the research, production, and sales of chemical raw materials and formulations [1] - The revenue composition of Anglikang's main business includes formulations at 43.46%, raw materials at 39.82%, specialty intermediates at 12.44%, others at 3.72%, and pharmaceutical excipients at 0.56% [1] Group 2 - From the perspective of fund holdings, one fund under AVIC Fund has a significant position in Anglikang. The fund "AVIC Preferred Navigation Mixed Initiation A" (022852) held 396,100 shares in the third quarter, accounting for 3.4% of the fund's net value, ranking as the tenth largest holding [2] - The "AVIC Preferred Navigation Mixed Initiation A" fund was established on December 24, 2024, with a latest scale of 60.61 million CNY. It has achieved a return of 73.81% this year, ranking 222 out of 8147 in its category [2] - The fund manager, Wang Sen, has been in position for 2 years and 48 days, managing total assets of 2.85 billion CNY. During his tenure, the best fund return was 136.74%, while the worst was 2.83% [2]